These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4850769)

  • 1. Bioavailability: a practitioner's point of view.
    Fedder DO
    J Am Pharm Assoc; 1974 Aug; 14(8):404-6. PubMed ID: 4850769
    [No Abstract]   [Full Text] [Related]  

  • 2. The pharmacist's ability to use bioavailability data.
    Cronk JD; Williams RB; Moore WE
    Am J Hosp Pharm; 1975 Jan; 32(1):46-8. PubMed ID: 1124781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologic availability and therapeutic equivalence.
    Arnold JD; Sicé J
    J Clin Pharmacol; 1976 Oct; 16(10 Pt 2):546-9. PubMed ID: 977793
    [No Abstract]   [Full Text] [Related]  

  • 4. Proceedings: Bioavailability and therapeutic efficacy.
    Withey RJ
    Rev Can Biol; 1973; 32():Suppl:21-30. PubMed ID: 4777602
    [No Abstract]   [Full Text] [Related]  

  • 5. Bioavailability, clinical effectiveness, and the public interest.
    Levy G
    Pharmacology; 1972; 8(1):33-43. PubMed ID: 4644654
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of bioavailability data by practitioners. Part 2: Preliminary report of evaluation skills of pharmacists and physicians.
    Vinson BE; Schumacher GE
    Am J Hosp Pharm; 1976 Nov; 33(11):1164-6. PubMed ID: 998634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug metabolism: an industrial research view of the future.
    Ober RE
    Drug Metab Rev; 1979; 10(2):315-9. PubMed ID: 551917
    [No Abstract]   [Full Text] [Related]  

  • 8. Bioavailability and generic prescribing.
    Mindel JS
    Surv Ophthalmol; 1976; 21(3):262-75. PubMed ID: 13505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioavailability and bioequivalence.
    Skelly JP
    J Clin Pharmacol; 1976 Oct; 16(10 Pt 2):539-45. PubMed ID: 977792
    [No Abstract]   [Full Text] [Related]  

  • 10. Product dissolution methods.
    Leeson LJ
    J Pharm Sci; 1973 Apr; 62(4):IV. PubMed ID: 4699003
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug product quality.
    J Am Pharm Assoc; 1970 Feb; 10(2):107-16. PubMed ID: 5411068
    [No Abstract]   [Full Text] [Related]  

  • 12. [Influence of the starting materials on bioavailability of drugs].
    Bagnaresi P; Bulgarelli D; Calvi A; Ferrarini G
    Boll Chim Farm; 1973 Feb; 112(2):83-93. PubMed ID: 4719968
    [No Abstract]   [Full Text] [Related]  

  • 13. Oral biopharmaceutics tools - time for a new initiative - an introduction to the IMI project OrBiTo.
    Lennernäs H; Aarons L; Augustijns P; Beato S; Bolger M; Box K; Brewster M; Butler J; Dressman J; Holm R; Julia Frank K; Kendall R; Langguth P; Sydor J; Lindahl A; McAllister M; Muenster U; Müllertz A; Ojala K; Pepin X; Reppas C; Rostami-Hodjegan A; Verwei M; Weitschies W; Wilson C; Karlsson C; Abrahamsson B
    Eur J Pharm Sci; 2014 Jun; 57():292-9. PubMed ID: 24189462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of physiologically relevant biopharmaceutics tools within the pharmaceutical industry and in regulatory sciences: Where are we now and what are the gaps?
    Flanagan T; Van Peer A; Lindahl A
    Eur J Pharm Sci; 2016 Aug; 91():84-90. PubMed ID: 27283487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bioavailability and biopharmaceutics].
    Colombo BM; Colombo MM; De Fusco R
    Boll Chim Farm; 1976 Mar; 115(3):231-41. PubMed ID: 1275980
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug bioavailability information and its utility.
    Chun AH; Seitz JA
    J Am Pharm Assoc; 1974 Aug; 14(8):407-14. PubMed ID: 4851441
    [No Abstract]   [Full Text] [Related]  

  • 17. [Methodological approach to the measure of the bioavailability of drugs in man (author's transl)].
    Lesne M
    J Pharm Belg; 1976; 31(1):5-24. PubMed ID: 768445
    [No Abstract]   [Full Text] [Related]  

  • 18. Dose-effect curves and relative biophasic drug levels: elucidation of these concepts and the illustration of their use for the determination of bioavailability, rate of absorption, and time course of pharmacological response.
    Weigand WA; Jhawar AK
    J Pharmacokinet Biopharm; 1976 Feb; 4(1):67-80. PubMed ID: 1271241
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug permeation through membranes. II. Simultaneous dissolution and permeation of drug from solid dosage forms.
    Lovering EG; McRae KB
    J Pharm Sci; 1973 Jun; 62(6):971-4. PubMed ID: 4712634
    [No Abstract]   [Full Text] [Related]  

  • 20. Paediatric biopharmaceutics classification system: current status and future decisions.
    Batchelor H;
    Int J Pharm; 2014 Aug; 469(2):251-3. PubMed ID: 24602991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.